Correlation Between C4 Therapeutics and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Foghorn Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Foghorn Therapeutics.
Diversification Opportunities for C4 Therapeutics and Foghorn Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CCCC and Foghorn is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Foghorn Therapeutics
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 1.54 times more return on investment than Foghorn Therapeutics. However, C4 Therapeutics is 1.54 times more volatile than Foghorn Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about 0.09 per unit of risk. If you would invest 173.00 in C4 Therapeutics on June 6, 2025 and sell it today you would earn a total of 94.00 from holding C4 Therapeutics or generate 54.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. Foghorn Therapeutics
Performance |
| Timeline |
| C4 Therapeutics |
| Foghorn Therapeutics |
C4 Therapeutics and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Foghorn Therapeutics
The main advantage of trading using opposite C4 Therapeutics and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| C4 Therapeutics vs. Foghorn Therapeutics | C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Kymera Therapeutics |
| Foghorn Therapeutics vs. Shattuck Labs | Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Climb Bio | Foghorn Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |